↓ Skip to main content

The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2 mouse model of Huntington's…

Overview of attention for article published in Molecular Neurodegeneration, June 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (73rd percentile)

Mentioned by

patent
2 patents

Citations

dimensions_citation
83 Dimensions

Readers on

mendeley
65 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2 mouse model of Huntington's disease
Published in
Molecular Neurodegeneration, June 2010
DOI 10.1186/1750-1326-5-26
Pubmed ID
Authors

Jonathan H Fox, Teal Connor, Vanita Chopra, Kate Dorsey, Jibrin A Kama, Dorothee Bleckmann, Claudia Betschart, Daniel Hoyer, Stefan Frentzel, Marian DiFiglia, Paolo Paganetti, Steven M Hersch

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 65 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 2%
Poland 1 2%
Belgium 1 2%
Unknown 62 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 21 32%
Student > Ph. D. Student 13 20%
Student > Bachelor 7 11%
Student > Master 7 11%
Student > Doctoral Student 5 8%
Other 4 6%
Unknown 8 12%
Readers by discipline Count As %
Agricultural and Biological Sciences 23 35%
Medicine and Dentistry 11 17%
Biochemistry, Genetics and Molecular Biology 8 12%
Neuroscience 6 9%
Chemistry 4 6%
Other 3 5%
Unknown 10 15%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 July 2016.
All research outputs
#4,716,329
of 22,873,031 outputs
Outputs from Molecular Neurodegeneration
#535
of 851 outputs
Outputs of similar age
#19,508
of 94,141 outputs
Outputs of similar age from Molecular Neurodegeneration
#1
of 3 outputs
Altmetric has tracked 22,873,031 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 851 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.2. This one is in the 36th percentile – i.e., 36% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 94,141 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them